Co-reporter:Michael S. Poslusney, Christian Sevel, Thomas J. Utley, Thomas M. Bridges, Ryan D. Morrison, Nathan R. Kett, Douglas J. Sheffler, Colleen M. Niswender, J.S. Daniels, P.J. Conn, Craig W. Lindsley, Michael R. Wood
Bioorganic & Medicinal Chemistry Letters 2012 Volume 22(Issue 22) pp:6923-6928
Publication Date(Web):15 November 2012
DOI:10.1016/j.bmcl.2012.09.011
Utilizing a combination of high-throughput and multi-step synthesis, SAR in a novel series of M1 acetylcholine receptor antagonists was rapidly established. The efforts led to the discovery the highly potent M1 antagonists 6 (VU0431263), and 8f (VU0433670). Functional Schild analysis and radioligand displacement experiments demonstrated the competitive, orthosteric binding of these compounds; human selectivity data are presented.